ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML patients with the b3a2 BCR-ABL1 transcript type, compared to those with the b2a2 transcript, demonstrate greater survival rates, while CML patients with the p190 transcript type are classified as high risk [20, 21].